Methods for diagnosing severe systemic lupus erythematosus
US7118865B2 · kind B2 · utility
16Cited by
2References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 16, 2002 |
| Grant date | Oct 10, 2006 |
| Priority date | — |
| Expiry date | Mar 5, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to methods and materials involved in diagnosing SLE. More particularly, the invention relates to methods and materials involved in diagnosing SLE, diagnosing severe SLE, and assessing a mammal's susceptibility to develop severe SLE. For example, the invention provides nucleic acid arrays that can be used to diagnose SLE in a mammal. Such arrays can allow clinicians to diagnose SLE based on a simultaneous determination of the expression levels of many genes that are differentially expressed in SLE patients as compared to healthy controls.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.